Andrew Hull

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hull:

Stock Role Class Num Shares Value Price $ Report Date Ownership
InMed Pharmaceuticals Inc. Director Common Stock 38.3K $14.9K $0.39 21 Feb 2024 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Right to Buy) 977 20 Dec 2024 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Expiration) 975 11 Jan 2025 Direct

Insider Reports Filed by Andrew Hull

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INM InMed Pharmaceuticals Inc. 11 Jan 2025 1 $0 4 Director 03 Feb 2025, 08:49
INM InMed Pharmaceuticals Inc. 20 Dec 2024 1 $0 4 Director 23 Dec 2024, 09:17
INM InMed Pharmaceuticals Inc. 21 Feb 2024 1 $14.6K 4 Director 22 Feb 2024, 13:38
INM InMed Pharmaceuticals Inc. 14 Jan 2024 1 $0 4 Director 05 Mar 2024, 15:20
INM InMed Pharmaceuticals Inc. 23 Dec 2023 1 $0 4 Director 26 Dec 2023, 13:04
INM InMed Pharmaceuticals Inc. 16 Dec 2022 1 $0 4 Director 19 Dec 2022, 15:51
INM InMed Pharmaceuticals Inc. 24 Jan 2022 1 $0 4 Director 24 Jan 2022, 15:17
INM InMed Pharmaceuticals Inc. 29 Dec 2021 1 $0 4 Director 30 Dec 2021, 17:02